9EP Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Enanta Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 11.3 EUR -2.59% Market Closed

Market Cap: €239.3m

E	Enanta Pharmaceuticals Inc F:9EP	US
	Camino Minerals Corp XTSX:COR	CA
C	Cardlytics Inc SWB:CYX	US
	Zonzia Media Inc OTC:ZONX	US
D	Departure Bay Capital Corp XTSX:DBC.P	CA
D	Diamond Fields Resources Inc OTC:DFIFF	CA
O	Odfjell SE XBER:O7F1	NO
	Deltic Energy PLC F:7RC0	UK
	Wavestone SA PAR:WAVE	FR
B	Benz Capital Corp XTSX:BCC.P	CA
M	Monstarlab Holdings Inc TSE:5255	JP
P	Pod Point Group Holdings PLC F:6EO	UK
I	Immunoprecise Antibodies Ltd NASDAQ:IPA	CA

Profitability Summary

Enanta Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-90%

Negative 3Y Average Operating Margin

-149%

Operating Margin is Increasing

-165% > -90%

Negative Net Margin

-97%

Negative 3Y Average Net Margin

-145%

Net Margin is Increasing

-164% > -97%

Negative Free Cash Flow Margin

-57%

Negative 3Y Average Free Cash Flow Margin

-100%

Free Cash Flow Margin is Increasing

-132% > -57%

Negative ROE

-70%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-93%

ROIC is Increasing

-119% > -60%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.